Loading…
Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution
Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the d...
Saved in:
Published in: | Journal of pharmaceutical sciences 2012-02, Vol.101 (2), p.641-663 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303 |
---|---|
cites | cdi_FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303 |
container_end_page | 663 |
container_issue | 2 |
container_start_page | 641 |
container_title | Journal of pharmaceutical sciences |
container_volume | 101 |
creator | Patel, Jagdishwar R. Carlton, Robert A. Yuniatine, Fnu Needham, Thomas E. Wu, Lianming Vogt, Frederick G. |
description | Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the dispersions, PVP is shown to improve physical properties and also assists in maintaining supersaturation in solution. The dispersions provide a twofold increase over equilibrium solubility at the same pH. The dispersions are characterized using electron microscopy, vibrational spectroscopy, diffuse-reflectance visible spectroscopy, and X-ray powder diffraction. The structures of the dispersions are probed using solid-state nuclear magnetic resonance (SSNMR) experiments applied to the 1H, 13C, and 15N nuclei, including two-dimensional dipolar correlation experiments that detect molecular association and the formation of a glass solution between tenoxicam, l-arginine, and PVP. Other aspects of the amorphous structure, including hydrogen-bonding interactions and the ionization state of tenoxicam and l-arginine, are also explored using SSNMR methods. These methods are used to show that the SDDs contain an amorphous l-arginine salt of tenoxicam in a glass solution that also includes PVP when present. Finally, the dispersions show only a minor decrease in chemical stability during accelerated stability studies relative to a crystalline form of tenoxicam. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association. |
doi_str_mv | 10.1002/jps.22800 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_913720256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915317287</els_id><sourcerecordid>3278525091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303</originalsourceid><addsrcrecordid>eNp10VFv0zAQB3ALgVgZPPAFUCSEEA_ZznbsJI9TNwrTBBMd4tFynYvqksaZndCVT49DuiEhePLD_Xz23Z-QlxROKAA73XThhLEC4BGZUcEglUDzx2QWayzlIiuPyLMQNgAgQYin5IgxKIUs5Yzsrj122uveujbRbZUsez-YfvC6SebrWDA9evtzqrs6Ods6363dEJJl5_U-PfcWq-Tchg59iCaM6AZbd2eN3iY726-Ti3atWzOx4Jph7PWcPKl1E_DF4TwmX99f3Mw_pFefFx_nZ1epyWQGaU0lozVnMmOZjr9GpqsSUPAiW7GVrIReGaqxlFywKk4rQSJyoJjlmDMO_Ji8nfp23t0OGHq1tcFg0-gW4xSqpDxnwISM8vVfcuMG38bPKSpozotC0lG9m5TxLgSPteq83Wq_VxTUGIaKYajfYUT76tBxWG2xepD324_gzQHoYHRT-7gmG_44IUDkWR7d6eR2tsH9_19Ul9fL-6fT6YYNPd493ND-u5I5z4X69mkR-7PLRQFf1Oj55DFm8cOiV8FYHEOzHk2vKmf_MeAvaNDA7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517388616</pqid></control><display><type>article</type><title>Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution</title><source>Wiley-Blackwell Journals</source><source>ScienceDirect Journals</source><creator>Patel, Jagdishwar R. ; Carlton, Robert A. ; Yuniatine, Fnu ; Needham, Thomas E. ; Wu, Lianming ; Vogt, Frederick G.</creator><creatorcontrib>Patel, Jagdishwar R. ; Carlton, Robert A. ; Yuniatine, Fnu ; Needham, Thomas E. ; Wu, Lianming ; Vogt, Frederick G.</creatorcontrib><description>Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the dispersions, PVP is shown to improve physical properties and also assists in maintaining supersaturation in solution. The dispersions provide a twofold increase over equilibrium solubility at the same pH. The dispersions are characterized using electron microscopy, vibrational spectroscopy, diffuse-reflectance visible spectroscopy, and X-ray powder diffraction. The structures of the dispersions are probed using solid-state nuclear magnetic resonance (SSNMR) experiments applied to the 1H, 13C, and 15N nuclei, including two-dimensional dipolar correlation experiments that detect molecular association and the formation of a glass solution between tenoxicam, l-arginine, and PVP. Other aspects of the amorphous structure, including hydrogen-bonding interactions and the ionization state of tenoxicam and l-arginine, are also explored using SSNMR methods. These methods are used to show that the SDDs contain an amorphous l-arginine salt of tenoxicam in a glass solution that also includes PVP when present. Finally, the dispersions show only a minor decrease in chemical stability during accelerated stability studies relative to a crystalline form of tenoxicam. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.22800</identifier><identifier>PMID: 22095696</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Hoboken: Elsevier Inc</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Biological and medical sciences ; Chromatography, Liquid ; dissolution ; General pharmacology ; infrared spectroscopy ; Magnetic Resonance Spectroscopy ; mass spectrometry ; Medical sciences ; microscopy ; Microscopy, Electron, Scanning ; Molecular Structure ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Piroxicam - analogs & derivatives ; Piroxicam - chemistry ; Powder Diffraction ; solid dispersion ; solid-state NMR ; solid-state stability ; Solubility ; Spectrophotometry, Infrared ; Spectrophotometry, Ultraviolet ; supersaturation ; thermal analysis ; X-ray diffractometry</subject><ispartof>Journal of pharmaceutical sciences, 2012-02, Vol.101 (2), p.641-663</ispartof><rights>2011 Wiley Periodicals, Inc.</rights><rights>Copyright © 2011 Wiley Periodicals, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303</citedby><cites>FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.22800$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022354915317287$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,1417,3549,27924,27925,45574,45575,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25505747$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22095696$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patel, Jagdishwar R.</creatorcontrib><creatorcontrib>Carlton, Robert A.</creatorcontrib><creatorcontrib>Yuniatine, Fnu</creatorcontrib><creatorcontrib>Needham, Thomas E.</creatorcontrib><creatorcontrib>Wu, Lianming</creatorcontrib><creatorcontrib>Vogt, Frederick G.</creatorcontrib><title>Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the dispersions, PVP is shown to improve physical properties and also assists in maintaining supersaturation in solution. The dispersions provide a twofold increase over equilibrium solubility at the same pH. The dispersions are characterized using electron microscopy, vibrational spectroscopy, diffuse-reflectance visible spectroscopy, and X-ray powder diffraction. The structures of the dispersions are probed using solid-state nuclear magnetic resonance (SSNMR) experiments applied to the 1H, 13C, and 15N nuclei, including two-dimensional dipolar correlation experiments that detect molecular association and the formation of a glass solution between tenoxicam, l-arginine, and PVP. Other aspects of the amorphous structure, including hydrogen-bonding interactions and the ionization state of tenoxicam and l-arginine, are also explored using SSNMR methods. These methods are used to show that the SDDs contain an amorphous l-arginine salt of tenoxicam in a glass solution that also includes PVP when present. Finally, the dispersions show only a minor decrease in chemical stability during accelerated stability studies relative to a crystalline form of tenoxicam. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Biological and medical sciences</subject><subject>Chromatography, Liquid</subject><subject>dissolution</subject><subject>General pharmacology</subject><subject>infrared spectroscopy</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>mass spectrometry</subject><subject>Medical sciences</subject><subject>microscopy</subject><subject>Microscopy, Electron, Scanning</subject><subject>Molecular Structure</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Piroxicam - analogs & derivatives</subject><subject>Piroxicam - chemistry</subject><subject>Powder Diffraction</subject><subject>solid dispersion</subject><subject>solid-state NMR</subject><subject>solid-state stability</subject><subject>Solubility</subject><subject>Spectrophotometry, Infrared</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>supersaturation</subject><subject>thermal analysis</subject><subject>X-ray diffractometry</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp10VFv0zAQB3ALgVgZPPAFUCSEEA_ZznbsJI9TNwrTBBMd4tFynYvqksaZndCVT49DuiEhePLD_Xz23Z-QlxROKAA73XThhLEC4BGZUcEglUDzx2QWayzlIiuPyLMQNgAgQYin5IgxKIUs5Yzsrj122uveujbRbZUsez-YfvC6SebrWDA9evtzqrs6Ods6363dEJJl5_U-PfcWq-Tchg59iCaM6AZbd2eN3iY726-Ti3atWzOx4Jph7PWcPKl1E_DF4TwmX99f3Mw_pFefFx_nZ1epyWQGaU0lozVnMmOZjr9GpqsSUPAiW7GVrIReGaqxlFywKk4rQSJyoJjlmDMO_Ji8nfp23t0OGHq1tcFg0-gW4xSqpDxnwISM8vVfcuMG38bPKSpozotC0lG9m5TxLgSPteq83Wq_VxTUGIaKYajfYUT76tBxWG2xepD324_gzQHoYHRT-7gmG_44IUDkWR7d6eR2tsH9_19Ul9fL-6fT6YYNPd493ND-u5I5z4X69mkR-7PLRQFf1Oj55DFm8cOiV8FYHEOzHk2vKmf_MeAvaNDA7g</recordid><startdate>201202</startdate><enddate>201202</enddate><creator>Patel, Jagdishwar R.</creator><creator>Carlton, Robert A.</creator><creator>Yuniatine, Fnu</creator><creator>Needham, Thomas E.</creator><creator>Wu, Lianming</creator><creator>Vogt, Frederick G.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201202</creationdate><title>Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution</title><author>Patel, Jagdishwar R. ; Carlton, Robert A. ; Yuniatine, Fnu ; Needham, Thomas E. ; Wu, Lianming ; Vogt, Frederick G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Biological and medical sciences</topic><topic>Chromatography, Liquid</topic><topic>dissolution</topic><topic>General pharmacology</topic><topic>infrared spectroscopy</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>mass spectrometry</topic><topic>Medical sciences</topic><topic>microscopy</topic><topic>Microscopy, Electron, Scanning</topic><topic>Molecular Structure</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Piroxicam - analogs & derivatives</topic><topic>Piroxicam - chemistry</topic><topic>Powder Diffraction</topic><topic>solid dispersion</topic><topic>solid-state NMR</topic><topic>solid-state stability</topic><topic>Solubility</topic><topic>Spectrophotometry, Infrared</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>supersaturation</topic><topic>thermal analysis</topic><topic>X-ray diffractometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patel, Jagdishwar R.</creatorcontrib><creatorcontrib>Carlton, Robert A.</creatorcontrib><creatorcontrib>Yuniatine, Fnu</creatorcontrib><creatorcontrib>Needham, Thomas E.</creatorcontrib><creatorcontrib>Wu, Lianming</creatorcontrib><creatorcontrib>Vogt, Frederick G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patel, Jagdishwar R.</au><au>Carlton, Robert A.</au><au>Yuniatine, Fnu</au><au>Needham, Thomas E.</au><au>Wu, Lianming</au><au>Vogt, Frederick G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2012-02</date><risdate>2012</risdate><volume>101</volume><issue>2</issue><spage>641</spage><epage>663</epage><pages>641-663</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the dispersions, PVP is shown to improve physical properties and also assists in maintaining supersaturation in solution. The dispersions provide a twofold increase over equilibrium solubility at the same pH. The dispersions are characterized using electron microscopy, vibrational spectroscopy, diffuse-reflectance visible spectroscopy, and X-ray powder diffraction. The structures of the dispersions are probed using solid-state nuclear magnetic resonance (SSNMR) experiments applied to the 1H, 13C, and 15N nuclei, including two-dimensional dipolar correlation experiments that detect molecular association and the formation of a glass solution between tenoxicam, l-arginine, and PVP. Other aspects of the amorphous structure, including hydrogen-bonding interactions and the ionization state of tenoxicam and l-arginine, are also explored using SSNMR methods. These methods are used to show that the SDDs contain an amorphous l-arginine salt of tenoxicam in a glass solution that also includes PVP when present. Finally, the dispersions show only a minor decrease in chemical stability during accelerated stability studies relative to a crystalline form of tenoxicam. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association.</abstract><cop>Hoboken</cop><pub>Elsevier Inc</pub><pmid>22095696</pmid><doi>10.1002/jps.22800</doi><tpages>23</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 2012-02, Vol.101 (2), p.641-663 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_proquest_miscellaneous_913720256 |
source | Wiley-Blackwell Journals; ScienceDirect Journals |
subjects | Anti-Inflammatory Agents, Non-Steroidal - chemistry Biological and medical sciences Chromatography, Liquid dissolution General pharmacology infrared spectroscopy Magnetic Resonance Spectroscopy mass spectrometry Medical sciences microscopy Microscopy, Electron, Scanning Molecular Structure Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Piroxicam - analogs & derivatives Piroxicam - chemistry Powder Diffraction solid dispersion solid-state NMR solid-state stability Solubility Spectrophotometry, Infrared Spectrophotometry, Ultraviolet supersaturation thermal analysis X-ray diffractometry |
title | Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A44%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preparation%20and%20Structural%20Characterization%20of%20Amorphous%20Spray-Dried%20Dispersions%20of%20Tenoxicam%20with%20Enhanced%20Dissolution&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Patel,%20Jagdishwar%20R.&rft.date=2012-02&rft.volume=101&rft.issue=2&rft.spage=641&rft.epage=663&rft.pages=641-663&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.22800&rft_dat=%3Cproquest_cross%3E3278525091%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1517388616&rft_id=info:pmid/22095696&rfr_iscdi=true |